Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-30
2010-12-14
Ha, Julie (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S009100, C514S279000, C424S116000, C424S117000, C540S455000
Reexamination Certificate
active
07851439
ABSTRACT:
Organic compounds that are useful for the treatment, prevention and/or amelioration of diseases are described.
REFERENCES:
patent: 5139778 (1992-08-01), Selva et al.
patent: 5202241 (1993-04-01), Selva et al.
patent: 5322777 (1994-06-01), Selva et al.
patent: 5514649 (1996-05-01), Selva et al.
patent: 5547666 (1996-08-01), Selva et al.
patent: 5599791 (1997-02-01), Tavecchia et al.
patent: 5747295 (1998-05-01), Selva et al.
patent: 5843890 (1998-12-01), Selva et al.
patent: 5882900 (1999-03-01), Rizzo et al.
patent: 5891869 (1999-04-01), Lociura et al.
patent: 6008225 (1999-12-01), Lociura et al.
patent: 6143739 (2000-11-01), Lociura et al.
patent: 0494078 (1992-07-01), None
patent: 0675900 (1998-02-01), None
patent: 9614427 (1996-05-01), None
patent: 03105881 (2003-12-01), None
patent: 2006086012 (2006-08-01), None
patent: 2007142986 (2007-12-01), None
Wolf H, Chinali G, Parmeggiani A, “Kirromycin, an Inhibitor of Protein Biosynthesis that Acts on Elongation Factor Tu,” Proceedings of National Academy of Sciences, USA, Dec. 1974, 71(12): 4910-4914.
Structure of Kirromycin (K1507) from SIGMA, pp. 1. Accessed Apr. 16, 2009.
Types of bacterial infection from Merck manual, http://www.merck.com/mmhe/sec17/ch190/ch190a.html, pp. 1-6. Accessed Apr. 16, 2009.
Definition of residue from http://dictionary.reference.com/browse/residue, pp. 1-4. Accessed Jul. 13, 2009.
Cislak Fe, “Pyridine-N-Oxide,” Industrial and Engineering Chemistry, 1955, 47(4): 800-802.
Atropisomer from http://www.allwords.com/word-atropisomer.html, pp. 1-2. Accessed Jul. 23, 2009.
Stereoisomer from http://www.chemicool.com/definition/stereoisomers.html, pp. 1-3. Accessed Jul. 23, 2009.
Rotamer from http://www.chemicool.com/definition/rotamer.html, pp. 1-2. Accessed Jul. 23, 2009.
Racemate from http://www.chemicool.com/definition/racemate.html, pp. 1-2. Accessed Jul. 23, 2009.
Enantiomer from http://www.chemicool.com/definition/enantiomer.html, pp. 1-2. Accessed Jul. 23, 2009.
Tautomer from http://medical-dictionary.thefreedictionary.com/tautomer, pp. 1-2. Accessed Jul. 23, 2009.
Pyridine N-Oxide from SIGMA.com, pp. 1-6. Accessed Jul. 23, 2009.
Diastereomer from http://www.allwords.com/word-diastereoisomer.html, pp. 1-2. Accessed Jul. 23, 2009.
Enrico, Selva et al. “Components of the GE2270 Complex Produced by Planobispora Rosea ATCC 53773” Journal of Antibiotics, Japan Antibiotics Research Association, Tokyo, JP vol. 48, No. 9, 1995, pp. 1039-1042.
International Search Report for related application PCT/US2007/012768 mailed Sep. 11, 2007.
Tavecchia, P. et al. “Degradation Studies of Antibiotic MDL 62,879 (GE2270A) and Revision of the Structure”, Tetrahedron vol. 51, No. 16. Great Britain, 1995, pp. 4867-4890.
Selva, E. et al “Antibiotic GE2270 A: A Novel Inhibitor of bacterial Protein Synthesis, I. Isolation and Characterization”, Journal of Antibiotics, vol. 44, No. 7, 1991, pp. 693-701.
Bushell Simon
LaMarche Matthew
Patane Michael J.
Whitehead Lewis
Alexander John
Ha Julie
Novartis AG
LandOfFree
EFTU inhibitors or aminothiazoles and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with EFTU inhibitors or aminothiazoles and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and EFTU inhibitors or aminothiazoles and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4211747